Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$170.78 - $208.42 $8.11 Million - $9.9 Million
-47,500 Reduced 52.78%
42,500 $7.82 Million
Q4 2023

Feb 14, 2024

BUY
$114.17 - $185.35 $10.3 Million - $16.7 Million
90,000 New
90,000 $16.2 Million
Q4 2020

Feb 16, 2021

SELL
$148.08 - $206.57 $12.3 Million - $17.2 Million
-83,400 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$122.51 - $158.27 $10.2 Million - $13.2 Million
83,400 New
83,400 $12.3 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.91B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.